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control. On cellular level, DAPK1 expression decreased 
in SGHPL-4 trophoblasts in response to TNF-α. Observed 
changes in the expression profile of autophagy-related 
genes were reflected by significantly decreased lipidation 
of autophagy marker microtubule-associated protein light 
chain 3 beta (LC3B-II) in first trimester placental explants 
in response to TNF-α. Analysis of TNF-α-treated term pla-
cental explants showed decreased DAPK1 protein, whereas 
in contrast to first-trimester LC3B expression and lipida-
tion increased. Immunohistochemistry of placental tissues 
from early-onset preeclampsia (PE) showed less DAPK1 
staining, when compared to controls. Accordingly, DAPK1 
mRNA and protein were decreased in primary trophoblasts 
isolated from early-onset PE, while LC3B-I and -II were 
increased. Results from this study suggest that DAPK1, a 
regulator of apoptosis, autophagy and programmed necro-
sis, decreases in human placenta in response to elevated 
maternal TNF-α, irrespective of gestational age. In con-
trast, TNF-α differentially regulates levels of autophagy 
marker LC3B in human placenta over gestation.
Keywords Pregnancy · Preeclampsia · Placenta · 
Trophoblast · Inflammation · Autophagy
Introduction
Concerted placenta development is mandatory for suc-
cessful human pregnancy and depends on a fine balanced 
cross-talk of immune-modulating factors between fetal 
and maternal tissues. Amongst immune-modulating fac-
tors, pro- and anti-inflammatory cytokines play a critical 
role in regulating cellular processes such as cell prolifera-
tion, differentiation as well as apoptosis to overall assure 
proper placental growth and development in particular 
Abstract Autophagy, a cell-survival process responsible 
for degradation of protein aggregates and damaged orga-
nelles, is increasingly recognized as another mechanism 
essential for human placentation. A substantial body of 
experiments suggests inflammation and oxidative stress as 
the underlying stimuli for altered placental autophagy, giv-
ing rise to placenta dysfunction and pregnancy pathologies. 
Here, the hypothesis is tested whether or not pro-inflam-
matory cytokines interleukin (IL)-6 and tumor necrosis 
factor (TNF)-α are able to influence the expression profile 
of autophagy genes in human first-trimester villous pla-
centa. Autophagy-focused qPCR arrays identified substan-
tial downregulation of death-associated protein kinase 1 
(DAPK1) in first-trimester placental explants in response 
to IL-6 and TNF-α, respectively. Immunohistochemistry 
of placental explants detected considerable DAPK1 stain-
ing in placental macrophages, villous cytotrophoblasts and 
less intense in the syncytiotrophoblast. Both immunohis-
tochemistry and Western blot showed decreased DAPK1 
protein in TNF-α-treated placental explants compared to 
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during very early phase of human pregnancy. At that stage, 
macroautophagy (herein referred to as autophagy)—a cell-
survival process responsible for degradation of aggregates 
of misfolded proteins or damaged organelles—is increas-
ingly recognized as essential to maintain a cellular balance 
between anabolic and catabolic processes, allowing appro-
priate growth of the embryo and placenta (Kanninen et al. 
2013). In normal gestation autophagy becomes activated 
early in human placenta and can be detected in placental 
key cells including cytotrophoblast, syncytiotrophoblast, 
and extravillous trophoblast, as well as maternal decidual 
stroma cells (Avagliano et  al. 2015). Hence, autophagy is 
considered as cytoprotective response to different stress 
signals, including starvation, pathogens, hypoxia, reactive 
oxygen species and cytokines (Schmeisser et al. 2014). For 
human placenta, even the mode of delivery seems to influ-
ence autophagic activity, with higher levels of autophagy 
markers in placentas from cesarean section compared to 
vaginal delivery (Signorelli et  al. 2011). A substantial 
body of in  vitro experiments using primary trophoblasts 
and cell lines suggests inflammation and oxidative stress 
as the underlying stimuli for altered placental autophagy, 
giving rise to pregnancy pathologies, such as preeclamp-
sia (Akaishi et al. 2014; Kalkat et al. 2013; Oh et al. 2008) 
and fetal growth restriction (Curtis et  al. 2013). On the 
basis of mRNA and protein levels of autophagy markers, 
such as the posttranslationally modified active form of 
microtubule-associated protein 1 light chain 3 beta (LC3B-
II), lysosome-associated membrane protein 2 (LAMP-2) 
and beclin-1, increased autophagy is described in placen-
tas from pregnancies complicated by fetal growth restric-
tion, with or without preeclampsia, but not for those with 
pre-eclampsia alone (Curtis et al. 2013; Hung et al. 2012). 
In contrast, other studies showed evidence for increased 
autophagy in placentas from hypertensive pregnancies, 
independent of the presence of growth restriction (Akaishi 
et  al. 2014; Oh et al. 2008). Besides hypertension, mater-
nal body mass index (BMI) and fetal sex seem to influence 
placental autophagy, as activation of autophagosomal for-
mation and autophagosome–lysosome fusion have been 
shown in placentas from male but not female offspring of 
overweight and obese women. However, total autophagic 
activity in these placentas appears to be decreased as evi-
denced by an increase in p62 and a decrease in lysosomal 
biogenesis (Muralimanoharan et al. 2016). Of note, obesity 
is accompanied by enhanced inflammatory conditions, with 
increased TNF-α and IL-6 levels (Gregor and Hotamisligil 
2011).
In preterm delivery cases with histological signs of 
inflammation, placental expression of autophagy marker 
LC3 is associated with the severity of fetal inflammation 
and is significantly decreased compared to age-matched 
controls (Avagliano et  al. 2016). Overall, a moderate to 
strong pro-inflammatory maternal environment in these 
pregnancy complications may be responsible for altered 
placental autophagy. Indeed, pro-inflammatory T helper 
1 (Th1) cytokines such as interleukin (IL)-1, IL-2, IL-6, 
tumor necrosis factor (TNF)-α, transforming growth fac-
tor (TGF)-β and interferon (IFN)-γ have been demonstrated 
to induce autophagy, whereas anti-inflammatory Th2 
cytokines IL-4 and IL-13 inhibit it (Harris 2011). However, 
it is increasingly acknowledged that metabolic and pro-
inflammatory conditions influence early placenta develop-
ment and functions in the first trimester of pregnancy long 
before any phenotypic changes become clinically appar-
ent (Catalano and deMouzon 2015). Dysregulation of the 
autophagy machinery in response to a pro-inflammatory 
environment may contribute to aberrant placenta develop-
ment and dysfunction. Thus, the question addressed was 
whether exogenously applied IL-6 and TNF-α, mimicking 
increased maternal pro-inflammatory cytokines, are able to 
influence the autophagy program on transcriptional level in 
human first-trimester villous placenta. Moreover, observed 
effects of TNF-α on autophagy markers in human first-tri-
mester placenta were compared to term placenta and early-
onset preeclampsia cases.
Materials and methods
Human placenta tissue samples
The study was approved by the ethical committee of the 
Medical University of Graz. First-trimester placenta tissues 
(n = 8, mean gestational week: 10.6 ± 1.8) were obtained 
with informed written consent from healthy women (mean 
maternal age: 26.0 ± 6.9  years; mean body mass index: 
21.2 ± 2.6) undergoing elective pregnancy terminations for 
psychosocial reasons. Term placentas for placental explant 
culture were obtained immediately after caesarean section 
(n = 3, mean gestational week: 39.7 ± 0.6) from healthy 
women with singleton pregnancies.
Placental explant culture
For placental explant culture villous tissues from human 
first-trimester and term placentas were washed thoroughly 
in buffered saline and dissected into small pieces of approx-
imately 5 mg moist mass. Placental explants were cultured 
in 12-well dishes (nunc, Thermo Scientific) and 2mL/well 
DMEM/F12 (1:1, Gibco) supplemented with 10% FCS, 
penicillin/streptomycin, amphotericin B, and L-glutamine 
in a hypoxic workstation (BioSpherix) under 2.5% oxygen 
(for first trimester) and 8% oxygen (for term), respectively, 
at 37 °C for 48h. For cytokine treatments, complete culture 
medium was supplemented with 10  ng/ml recombinant 
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human IL-6 (Peprotech) and recombinant human TNF-α 
(Peprotech), respectively. Cultivation of explants in com-
plete culture medium without cytokines served as controls. 
After incubation, placental explants were homogenized for 
RNA isolation using peqGOLD TriFast reagent (Peqlab, 
Erlangen, Germany) and a tissue homogenizer (IKA TA10 
basic, Ultra-Turrax). A proportion of placental explants 
cultured in the same experimental setup were either for-
malin fixed and paraffin embedded (FFPE) for subsequent 
immunohistochemistry or homogenized in RIPA buffer 
(Sigma-Aldrich; St. Louis, MO, USA) including Protease 
Inhibitor Cocktail (Roche Diagnostics; Mannheim, Ger-
many) for Western blot analyses. Homogenates were cen-
trifuged at 8000×g and 4 °C for 10 min. Concentration of 
total tissue protein was determined in homogenates accord-
ing to Lowry method.
Analysis of placental explant viability
Potential cytotoxic effects of IL-6 and TNF-α on placental 
explants were evaluated by measurement of released lac-
tate dehydrogenase (LDH) activity in culture supernatants 
using LDH Cytotoxicity Detection Kit (Takara Bio Inc., 
eubio; Vienna; Austria) according to the manufacturer’s 
protocol. Obtained absorbance values were normalized to 
total protein of respective explant homogenates.
Isolation of primary trophoblasts from human placenta
Human placenta sampling was approved by the Regional 
Committee of the Medical Faculty of Charité Berlin. Pri-
mary trophoblasts were isolated from chorionic villi by 
enzymatic digestion and Percoll density gradient cen-
trifugation as previously described (Przybyl et  al. 2016). 
Primary trophoblasts were isolated from placentas of 
uncomplicated pregnancies collected following caesarean 
section at term (control trophoblasts, n = 6) and from pla-
centas of pregnancies complicated by early-onset preec-
lampsia (n = 5). Early-onset preeclampsia was defined by 
hypertension (SBP ≥ 140 mmHg or DBP ≥ 90 mmHg) and 
proteinuria (≥0.3 g in a 24-h urine specimen) before 34th 
gestational week according to the American College of 
Obstetricians and Gynecologists (ACOG) classification.
Cell culture
Trophoblast cell line SGHPL-4 was a kind gift from Judith 
E. Cartwright (St. George’s University of London, Lon-
don, United Kingdom) and was cultivated in HAM’s F10 
(Biochrom) media containing 10% (v/v) FCS and 1% (v/v) 
P/S. For expression analysis, starved SGHPL-4 cells were 
stimulated with 10  ng/ml TNF-α (Sigma-Aldrich). Total 
mRNA was isolated at indicated time points using QIAzol 
lysis reagent and Qiagen RNeasy mini-kit (Qiagen) with 
on-column deoxyribonuclease I step (Qiagen) according to 
the manufacturer’s protocol.
Gene expression analysis
Total RNA from placental tissue was isolated with peq-
GOLD TriFast reagent according to the manufacturer’s 
protocol. For human autophagy PCR array, RNA was sub-
jected to quality check and cDNA synthesis using the  RT2 
First Strand Kit (Qiagen) according to the manufacturer’s 
manual. In brief, total RNA from explants of each treatment 
was pooled and 1 µg was used for genomic DNA elimina-
tion and reverse transcription. cDNA was used for the real-
time Human Autophagy RT² Profiler PCR Array (PAHS-
084Z, Qiagen) in combination with RT² SYBR Green 
qPCR Mastermix (Qiagen) on a Bio-Rad CFX96 Real-
Time PCR System. cDNA of each treatment was run on 
a single plate and automatically generated Ct values were 
analyzed using the data analysis web portal http://www.qia-
gen.com/geneglobe. All samples passed PCR array repro-
ducibility, RT efficiency and genomic DNA elimination. 
Fold change was calculated using ΔΔCt method, in which 
ΔCt was calculated between gene of interest and arithme-
tic mean of two normalization genes hypoxanthine–guanine 
phosphoribosyltransferase (HPRT1) and ribosomal protein 
P0 (RPLP0).
Results from human autophagy PCR array were evalu-
ated for selected genes by probe-based qPCR. For this pur-
pose, 2 µg of total RNA from each sample was individually 
reverse transcribed to cDNA, using High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems; Foster 
City, CA, USA). cDNA was subsequently subjected to 
qPCR using TaqMan Gene Expression Assays for Cathep-
sin D (CTSD, Hs00157205_m1), Death-associated protein 
kinase 1 (DAPK1, Hs00234480_m1), and Histone dea-
cetylase 6 (HDAC6, Hs00195869_m1), and the TaqMan 
Universal PCR Mastermix (Applied Biosystems). cDNA 
and kit components were mixed in 20 µl total volume/well 
(96-well plates, Roche, Mannheim, Germany) according to 
the manufacturer’s instructions and amplified using a Bio-
Rad CFX96 Real-Time PCR System. Expression of LC3B 
was analyzed as previously described (Prokesch et al. 2016) 
using SYBR Green chemistry (Bio-Rad, Hercules, CA, 
USA) and specific primers for MAP1LC3B (MAP1LC3B_
For: AAG GCG CTT ACA GCT CAA TG and MAP1LC3B_
Rev: CTG GGA GGC ATA GAC CAT GT). Ct values were 
automatically generated by the CFX Manager 2.0 Software 
(Bio-Rad) and relative quantification of gene expression 
was calculated by standard ΔCt method using the expres-
sion of RPL30 and 18S as references. Data are presented as 
mean of  2−ΔCt values. Gene expression in SGHPL-4 troph-
oblasts was analyzed on ABI 7500 Fast Sequence Detection 
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System (Applied Biosystems) and analyzed by 7500 Fast 
System Software (Applied Biosystems).
Immunohistochemistry
FFPE placental sections  (5  μm) were mounted on Super-
frost Plus slides (Menzel/Thermo Fisher Scientific) and 
deparaffinized according to the standard protocol. Slides 
were boiled in epitope retrieval solution pH 8.0 (Novocas-
tra, Leica) for 7  min at 120 °C using a decloaking cham-
ber (Biocare Medical). Immunostaining was performed 
with the UltraVision Detection System HRP Polymer 
Kit (Thermo Fisher Scientific) as previously described 
(Blaschitz et al. 2015; Siwetz et al. 2015). In brief, endog-
enous peroxidase was blocked using the hydrogen per-
oxidase block for 10  min. Three washing steps with TBS 
including 0.05% Tween 20 (TBS/T; Merck) were fol-
lowed by background blocking with UltraVision Protein 
Block for 5  min. Polyclonal rabbit anti-DAPK1 antibody 
(ab200549, abcam) was diluted to a final concentration 
of 1  µg/ml in Antibody Diluent (Dako) and incubated on 
slides for 45  min at RT. Thereafter slides were washed 
three times and detection was achieved by incubation with 
anti-rabbit UltraVision HRP-labelled polymer (15 min) and 
3-amino-9-ethylcarbacole (AEC, Thermo Scientific) for 
10 min. Nuclei were stained with hemalaun and slides were 
mounted with aqueous mounting agent Aquatex (Merk Mil-
lipore). For negative control, slides were incubated with 
negative control for rabbit IgG (Neomarkers, ThermoSci-
entific, USA) at the same concentration as for anti-DAPK1 
antibody.
Western blot analysis
Placental explants were washed with PBS after culture and 
homogenized in RIPA buffer including protease inhibi-
tor cocktail. Primary trophoblasts were lysed in RIPA 
buffer after cell isolation procedure. Protein concentration 
was determined according to Lowry method and 40 µg of 
total protein was separated on precast 10% Bis-Tris gels 
(NuPAGE, Novex; lifetechnologies). Electrophoresis was 
followed by semi-dry blotting of proteins on 0.45-µm 
nitrocellulose membrane (Hybond, GE Healthcare Life 
Sciences) and blotting efficiency was determined by stain-
ing membranes with Ponceau S solution (Sigma-Aldrich). 
Immunodetection was performed with a chemilumines-
cent immunodetection kit (Amersham ECL Prime Western 
blotting detection Reagent, GE Healthcare Life Sciences) 
according to the manufacturer’s instructions. Membranes 
were cut into horizontal strips at molecular weight ranges 
for target proteins. Polyclonal rabbit anti-DAPK1 antibody 
(1:1000, ab200549, abcam), polyclonal LC3B/MAP1LC3B 
antibody (1:1000, NB100-2220, novusbio) and monoclonal 
anti-beta actin antibody (1:20,000; clone AC-15, abcam) 
were diluted in blocking solution and membrane strips were 
incubated overnight at 4 °C. Images were acquired with 
FluorChem Q System (Alpha Innotech, Cell Bioscienes, 
Santa Clara, CA, USA) and band densities were analyzed 
with Alpha View SA software 3.4.0. Results are presented 
as a ratio of relative DAPK1 or LC3B and beta-actin band 
densities.
Statistical analysis
Data were analyzed using GraphPad Prism 5.01 for 
Windows (GraphPad Software, San Diego California 
USA, http://www.graphpad.com) and are presented as 
means ± SEM. Data were subjected to D’Agostino and 
Pearson omnibus normality test. In case of normally dis-
tributed data, differences between groups were tested using 
paired two-tailed t test. For multiple comparison proce-
dure, one-way repeated measures analysis of variance was 
followed by Dunnett’s multiple comparison test to isolate 
groups that differ from control. p < 0.05 was considered sta-
tistically significant.
Results
To determine effects of an inflammatory microenviron-
ment on the placental gene expression profile of genes 
involved in autophagy early in gestation, human placental 
explants from first trimester of pregnancy were incubated 
in the presence or absence of pro-inflammatory cytokines 
IL-6 and TNF-α, respectively. Analysis of LDH release 
into the culture medium did not show significant differ-
ences between treatments, suggesting no cytotoxic effects 
of cytokines at used concentrations (data not shown). How-
ever, analysis of expression profile of 84 autophagy-related 
genes in first-trimester placental explants showed a similar 
shift in the presence of IL-6 and TNF-α after 48h culture. 
Comparison of normalized expression of every gene on the 
array between cytokine-treated explants and controls indi-
cated a higher proportion of downregulated than upregu-
lated genes (Fig. 1). Amongst the array of analyzed genes 
78.1 and 63.5% were downregulated in the presence of IL-6 
and TNF-α, respectively. Notably, in both IL-6- and TNF-
α-treated first-trimester placental explants, autophagy-
related 9B (ATG9B), C-X-C chemokine receptor type 4 
(CXCR4), and histone deacetylase 1 (HDAC1) were the 
three most upregulated genes, ranging from 1.49- to 1.63-
fold upregulation, when compared to control. In contrast, 
IL-6 treatment induced 2.08- and 2.05-fold downregulation 
of cathepsin D (CTSD) and death-associated protein kinase 
1 (DAPK1), respectively. In TNF-α-treated first-trimester 
placental explants, nine autophagy-related genes were more 
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than twofold downregulated, including, CTSD (−2.17-
fold), heat-shock 70-kDa protein 8 (HSPA8, −2.27-fold), 
DAPK1 (−2.34-fold), nuclear factor of kappa light poly-
peptide gene enhancer in B cells 1 (NFKB1, −2.35-fold), 
tumor necrosis factor superfamily, member 10 (TNFSF10, 
−2.40-fold), and histone deacetylase 6 (HDAC6, −2.56-
fold), as the most downregulated. Interestingly, unsuper-
vised hierarchical clustering of the entire array dataset indi-
cated similar regulatory effects on autophagy-related genes 
by IL-6 and TNF-α, respectively (Fig. 1).
Next, results from autophagy PCR array were evalu-
ated in individual first-trimester explant samples for three 
top-ranked downregulated genes (CTSD, DAPK1, and 
HDAC6) by qPCR analysis using a different set of prim-
ers. CTSD (−1.38- and −1.04-fold) and HDAC6 expres-
sion (−1.03- and −1.33-fold) were slightly, but not signifi-
cantly downregulated in the presence of IL-6 and TNF-α, 
respectively (Fig. 2a, b). However, DAPK1 showed a sub-
stantial 3.40- and significant 6.58-fold (p < 0.05) down-
regulation by IL-6 and TNF-α, respectively (Fig. 2c). Since 
effects of IL-6 did not reach statistical significance, further 
experiments were performed only with or without TNF-α 
treatments.
Immunohistochemistry of first-trimester placental 
explants detected marked DAPK1 staining in placental 
macrophages (Hofbauer cells) and the villous trophoblast 
layer, where cytotrophoblasts showed more intense stain-
ing than the syncytiotrophoblast (Fig.  3a). TNF-α-treated 
first-trimester placental explants showed a similar, but less 
pronounced staining of villous trophoblasts compared with 
controls (Fig.  3b). Western blot analysis of first-trimester 
placental explants detected DAPK1 protein at a molecu-
lar weight of approximately 160  kDa (Fig.  3d). Placental 
DAPK1 protein levels decreased by 27.1% in response to 
TNF-α, which, however, did not reach statistical signifi-
cance (Fig.  3e). Accordingly, on cellular level, DAPK1 
mRNA expression significantly decreased in first-trimester 
trophoblast cell line SGHPL-4 during a 120-h TNF-α treat-
ment (Fig. 3f).
To test whether or not cytokine-induced changes in 
the expression profile of autophagy-related genes were 
reflected by altered placental autophagy, effects of TNF-α 
on autophagy marker LC3B were analyzed in first-trimes-
ter placental explants. qPCR analysis of the LC3B gene 
MAP1LC3B did not show regulation by TNF-α on mRNA 
expression (Fig.  4a), confirming data from autophagy 
array. On protein level, LC3B appears in two variants: as 
unmodified, cytosolic variant (LC3B-I) and the posttrans-
lationally processed LC3B-II, which undergoes lipida-
tion with phosphatidylethanolamine and binds to the outer 
membrane of autophagosomes. Increase in LC3B-II is, 
therefore, a marker of activated autophagy (Klionsky et al. 
2016). Accordingly, Western blot analysis of first-trimester 
placental explants for LC3B detected two bands at approxi-
mately 19 and 17 kDa corresponding to LC3B-I and LC3B-
II, respectively. Interestingly, levels of placental LC3B-
II were consistently stronger than LC3B-I, irrespective 
Fig. 1  Hierarchical clustering of autophagy-related genes in IL-6- 
and TNF-α-treated placental explants. Human first-trimester pla-
cental explants from different patients (n = 8) were incubated with 
or without IL-6 (10 ng/ml) and TNF-α (10 ng/ml), respectively, for 
48h. RNA from each treatment group was pooled and subjected to 
autophagy qPCR array. The heat map with dendrograms shows log2 
fold-changes in blue for downregulated and in red for upregulated 
autophagy-related genes in IL-6-treated (left column) and TNF-α- 
treated (right column) placental explants relative to untreated controls
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of the presence or absence of TNF-α (Fig.  4b). However, 
while levels of LC3B-I remained unchanged, incubation 
with TNF-α decreased placental LC3B-II levels by 21.5% 
(p = 0.025) when compared to controls (Fig.  4b–d). This 
TNF-α-mediated reduction in autophagy is consistent with 
the predominant downregulation of autophagy-related 
genes, such as DAPK1.
Next we tested whether or not effects observed for first 
trimester also apply for term placenta tissue. For this pur-
pose, term placental explants were incubated in the pres-
ence or absence of TNF-α. While qPCR analysis revealed 
no change on DAPK1 mRNA levels (data not shown), 
DAPK1 protein levels decreased by 34.8% in response to 
TNF-α, which, however, did not reach statistical signifi-
cance (Fig. 5a, b). Analysis of autophagy marker LC3B in 
term placental explants showed a non-significant 1.23-fold 
increase in MAP1LC3B mRNA expression in response to 
TNF-α (Fig.  5c). On protein level, LC3B protein showed 
a similar picture as in first trimester, with consistently 
stronger LC3B-II than LC3B-I levels, irrespective of treat-
ment (Fig. 5a). However, in contrast to first trimester, both 
LC3B-I (p = 0.016) and LC3B-II levels increased in term 
placental explants in response to TNF-α treatment (Fig. 5d, 
e).
Finally, DAPK1 expression and autophagy marker 
LC3B were analyzed in placental tissue and primary troph-
oblasts isolated from placentas complicated by early-onset 
preeclampsia (PE), a condition associated with increased 
maternal circulating pro-inflammatory cytokines (Lau et al. 
2013). Immunohistochemistry of placental tissues from 
control (Fig.  6a) and early-onset PE (Fig.  6b) localized 
DAPK1 in the syncytiotrophoblast, which was less stained 
in early-onset PE cases, compared to controls. Consistently, 
primary trophoblasts isolated from placentas complicated 
by early-onset PE showed a 1.77-fold (p < 0.05) decrease 
in DAPK1 mRNA expression, when compared to tropho-
blasts isolated from healthy control placentas (Fig.  6c). 
On protein level, both DAPK1 and LC3B showed strong 
within-group variations, in both controls and PE cases. 
However, downregulation of DAPK1 was confirmed by 
trend, showing a decrease by 21.6% in trophoblasts from 
early-onset PE (Fig.  6d, e). Analysis of LC3B levels in 
these samples revealed a 1.36- and 1.62-fold increase in 
LC3B-I and LC3B-II levels, respectively, in trophoblasts 
isolated from preeclamptic placentas, when compared to 
controls (Fig. 6d, f, g).
Discussion
Here we report the first study evaluating effects of TNF-α 
treatment on DAPK1 and autophagy marker LC3B in first-
trimester and term placental tissue. We show that placen-
tal DAPK1 protein is downregulated in response to TNF-
α, irrespective of gestational age, whereas regulation of 
placental LC3B expression and its lipidation seem to dif-
fer between first-trimester and term of human pregnancy. 
Consistent with findings in TNF-α-treated term placental 
explants, we show that LC3B-I and II levels are increased 
in primary trophoblasts from early onset PE, while DAPK1 
is decreased compared to controls. Based on these obser-
vations, it is tempting to speculate that elevated maternal 
TNF-α levels dysregulate autophagic machinery in human 
placenta through different routes depending on different 
stages of gestation.
The expression profiles of genes involved in autophagy 
seem to be largely overlapping in human first-trimester vil-
lous placenta in response to inflammatory cytokines IL-6 
and TNF-α. While TNF-α elicits transcriptional regula-
tion mainly via JNK (Kalliolias and Ivashkiv 2016), IL-6 
receptor signaling is relayed to the nucleus via JAK/STAT 
signaling (Hunter and Jones 2015). However, both signal-
ing cascades involve the NFκB and ERK pathways which 
could be the common factors leading to similar transcrip-
tional responses in first-trimester placental explants. In this 
regard, both cytokines seem to have a similar regulatory 
Fig. 2  Expression analysis of 
CTSD, HDAC6, and DAPK1 
in IL-6- and TNF-α-treated 
placental explants. Human 
first-trimester placental explants 
(n = 8) were incubated with or 
without IL-6 (10 ng/ml) and 
TNF-α (10 ng/ml), respectively, 
for 48h. qPCR analysis was per-
formed for CTSD (a), HDAC6 
(b), and DAPK1 (c). Values are 
given as mean ± SEM. *p < 0.05
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role, with a much higher proportion of downregulated, 
compared to upregulated autophagy-related genes. Results 
from autophagy array and targeted qPCR analysis show 
good concordance for downregulation of placental DAPK1, 
whereas autophagy array data for CTSD and HDAC6 
are only confirmed by trend. This may be explained by 
Fig. 3  DAPK1 protein expression in TNF-α treated placental 
explants. Human first trimester placental explants were either treated 
in the absence (a) or presence (b) of TNF-α (10  ng/ml) for 48h. 
Immunohistochemistry detected DAPK1 in Hofbauer cells (open 
arrowhead), villous cytotrophoblasts (black arrowhead) and with less 
intensity in the syncytiotrophoblast (arrow). Incubation with nega-
tive control rabbit IgG (c) revealed no staining. Scale bar represents 
50 µm. Western blot analysis (d) of placental explants treated with or 
without TNF α (10 ng/ml) for 48h and band densitometry of placental 
DAPK1 levels (e) in response to cytokine treatment. Band densities 
of DAPK1 were related to corresponding densities of β-actin. Data 
are presented as mean ± SEM from five different explant cultures. 
Trophoblast cell line SGHPL-4 was treated with or without TNF α 
(10 ng/ml) for up to 120 h and DAPK1 expression was analyzed by 
qPCR (f). Data are presented as mean ± SEM from three independent 
experiments. *p < 0.05, ***p < 0.001
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differences in experimental setup, including sample pool-
ing for PCR array, differences in primer sequences and use 
of different reference genes. However, data from West-
ern blotting and immunohistochemistry support gene 
expression data and overall suggest downregulation of 
placental DAPK1 in response to TNF-α in first trimester 
of pregnancy. This is in agreement with studies, suggest-
ing DAPK1 inhibition on a transcriptional level by the 
pro-inflammatory transcription factors STAT3 and NFκB 
(Benderska and Schneider-Stock 2014), both of which 
are downstream players in the IL-6 and/or TNF-α signal-
ing. DAPK1 plays key roles in various signaling processes 
including apoptosis and autophagy (Bialik and Kimchi 
2006; Jin et  al. 2006). One of its actions is phosphoryla-
tion of beclin 1, which then dissociates from its inhibiting 
anti-apoptotic protein Bcl-XL and associates with phos-
phatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3) 
to induce autophagy (Zalckvar et  al. 2009). Recently, 
DAPK1 has been suggested to contribute to resveratrol-
induced autophagy in human dermal fibroblasts (Choi 
et al. 2013). In these cells, resveratrol treatment increased 
levels of LC3-II and GFP-LC3 punctate foci, reflecting 
its subcellular localization in autophagosomes, whereas 
DAPK1 silencing significantly attenuated observed effects. 
In agreement with that study, knockdown of DAPK1 in the 
hepatoma cell line HepG2 significantly decreased the LC3-
II/I ratio in quinocetone-induced autophagy (Zhou et  al. 
2016). Together, these studies and our results in first-tri-
mester placentas suggest that DAPK1 expression is directly 
associated with LC3-II levels in the autophagy process. 
However, our data from term placenta explants suggest that 
TNF-α-dependent regulation of the DAPK1 / LC3B axis 
may change during gestation. While at late stages of preg-
nancy DAPK1 still decreases in response to TNF-α, LC3B 
expression and lipidation in turn increase, suggesting 
uncoupling of placental DAPK1 levels from LC3B regula-
tion at term of pregnancy.
Increased TNF-α is associated with a number of adverse 
pregnancy conditions including gestational hypertension 
and gestational diabetes mellitus (GDM) (Pantham et  al. 
2015; Peracoli et  al. 2007). Since DAPK1 is upregulated 
in placentas from GDM pregnancies, our results suggest 
Fig. 4  LC3B levels in TNF-
α-treated placental explants. 
Human first-trimester placental 
explants were incubated with 
or without TNF-α (10 ng/
ml) for 48h. qPCR analysis 
of LC3B gene expression (a), 
Western blot analysis (b) and 
band densitometry data for 
LC3B-I (c) and LC3B-II (d), 
respectively, which were related 
to corresponding densities of 
β-actin. Data are presented as 
mean ± SEM from eight (a) 
and five (b–d) different explant 
cultures. *p < 0.05
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that rather the diabetic milieu or factors other than IL-6 
and TNF-α regulate placental DAPK1 in diabetic preg-
nancies (Magee et  al. 2014). At this point it should be 
stressed that besides TNF-α other inflammatory cytokines 
have been shown to induce DAPK1 expression in differ-
ent cell models. Accordingly, transforming growth factor 
(TGF)-β treatment rapidly induced DAPK mRNA and pro-
tein expression in Hep3B hepatoma cells (Jang et al. 2002). 
Moreover, studies with mouse embryonic fibroblasts and 
bone marrow-derived macrophage cell lines suggest IFN-γ-
induced DAPK1 upregulation through transcription factors 
C/EBP-β and ATF6 (Gade et al. 2008, 2012).
According to our array and qPCR data, first trimester 
placental LC3B (MAP1LC3B) mRNA expression seems to 
be unchanged in response to inflammatory cytokines IL-6 
and TNF-α, which is in contrast to another study showing a 
significant reduction of LC3B expression in chorion laeve 
of pre-term delivery cases with signs of histological inflam-
mation compared to cases without inflammatory lesions. 
This discrepancy may be explained by different gesta-
tional age of placenta samples, again suggesting gestational 
age-dependent changes in placental LC3B regulation in 
response to inflammatory cytokines. In our study, both first-
trimester and term placenta predominantly shows the lipi-
dated form of posttranslationally processed LC3B protein 
(LC3B-II). This is in line with previous studies in second 
trimester and term placenta (Oh et  al. 2008), suggesting 
induction of autophagy at all stages of pregnancy. Of note 
is that a previous correlation analysis suggested decreasing 
LC3B-II levels with advancing gestational week (Akaishi 
et al. 2014). However, our observation of decreased LC3B-
II in first-trimester placenta in response to TNF-α is in 
stark contrast to a previous study showing increased LC3B-
II levels in TNF-α-treated Jeg-3 trophoblast cells (Oh et al. 
2008). This discrepancy may be explained by the cancerous 
character of the choriocarcinoma cell line Jeg-3, whereas 
villous trophoblasts in placental explants remain in situ in 
their natural microenvironment. Additionally, Jeg-3 cells 
show a point mutation in one allele of the coding region of 
the p53 gene (Yaginuma et al. 1995). Since p53 is a regula-
tor of autophagy and a direct substrate of DAPK1 (Bialik 
and Kimchi 2014; Feng et al. 2015), results in Jeg-3 cells 
may be explained by altered p53 downstream effects.
While a number of studies have demonstrated a role 
for TNF-α in stimulating autophagy in various cells, 
including macrophages, vascular smooth muscle, and 
skeletal muscle cells, its regulation is still not completely 
understood and may clearly differ between different 
cell types and tissues (Harris 2011) and developmental 
stages. For human placenta, autophagy is considered as 
crucial mechanism to adapt to maternal stress situations 
and disruption of this mechanism may contribute to pla-
cental dysfunction. We conclude that increased mater-
nal TNF-α provokes a shift in the expression profile of 
Fig. 5  DAPK1 and LC3B 
levels in TNF-α treated term 
placental explants. Human term 
placental explants were incu-
bated with or without TNF-α 
(10 ng/ml) for 48h. Western blot 
analysis of DAPK1 and LC3B 
isoforms (a) and band densi-
tometry data for DAPK1 protein 
(b), qPCR analysis of LC3B 
gene expression (c), as well 
as band densitometry data for 
LC3B isoforms LC3B-I (d) and 
LC3B-II (e), respectively, which 
were related to corresponding 
densities of β-actin. Data are 
presented as mean ± SEM from 
three different explant cultures. 
*p < 0.05
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genes involved in autophagy, which in first trimester of 
pregnancy is characterized by a higher proportion of 
downregulated than upregulated placental genes. Down-
regulation of placental DAPK1, a regulator of apoptosis, 
autophagy, and programmed necrosis, may consequently 
lead to an unbalanced crosstalk between these path-
ways, entailing different regulation routes of placental 
autophagy at different stages of human gestation.
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Fig. 6  DAPK1 expression and 
LC3B levels in trophoblast and 
placentas from pregnancies 
complicated by preeclampsia. 
Immunohistochemistry for 
DAPK1 in placental tissue sec-
tions from control (a) and early-
onset preeclampsia (b). Scale 
bar represents 50 µm. DAPK1 
expression was analyzed by 
qPCR in primary trophoblasts 
isolated from control placentas 
(n = 6) and placentas from early-
onset preeclampsia (early PE, 
n = 5) (c). Western blot analysis 
(d) and band densitometry data 
for DAPK1 protein (e), and 
LC3B isoforms LC3B-I (f) and 
LC3B-II (g), respectively, in 
primary trophoblasts isolated 
from control (n = 6) and early 
PE (n = 5) placentas. Band 
densities of target proteins 
were related to correspond-
ing densities of β-actin. Data 
are presented as mean ± SEM. 
*p < 0.05
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